Skip to content

Research on the Effect and Mechanism of Filiform Fire Needle Therapy in the Treatment of Non-segmental Stable Vitiligo Based on the Theory of "Treating Cold Syndrome with Heat-natured Therapies"

Research on the Effect and Mechanism of Filiform Fire Needle Therapy in the Treatment of Non-segmental Stable Vitiligo Based on the Theory of "Treating Cold Syndrome with Heat-natured Therapies"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001434
Enrollment
Unknown
Registered
2025-07-20
Start date
2024-03-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Treatment group:Milli fire needle

Sponsors

The Fourth Clinical Medical College of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnosis of vitiligo; (2) vitiligo staged in a non-segmental stable stage; (3) the location of the skin lesion is located in the waist and abdomen; (4) Age 35-50 years old gender is not limited; (5) Those who have not received fire acupuncture treatment within one month before enrollment; (6) Good patient compliance.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women (2) Those with severe mental illness; (3) Those with severe cardiovascular and cerebrovascular diseases hematologic diseases severe hypertension severe diabetes and other major diseases; (4) Those with scar constitution or allergic constitution; (5) Patients who have participated in clinical trials of other drugs within 1 month or are participating in clinical trials of other drugs.

Design outcomes

Primary

MeasureTime frame
Differential genes;

Countries

China

Contacts

Public ContactZhang chenghui

The Affiliated Hospital of Traditional Chinese Medicine of Xinjiang Medical University

470703367@qq.com13899958530

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026